KCAS Bio will participate in the ACT 46th Annual Meeting, taking place November 16-19 in Phoenix, Arizona.
The ACT Meeting gathers the toxicology community for four days of scientific exchange, networking, and professional development. With a strong focus on applied toxicology, the meeting features a robust scientific program, including symposia, workshops, continuing education courses, and poster presentations. The meeting offers attendees valuable opportunities to stay current with regulatory trends, share research findings, and collaborate across the industry in an interactive environment.
Applications of Toxicology at KCAS Bio
As a leading bioanalytical CRO, KCAS Bio provides specialized services that support non-clinical safety assessment and toxicology research. Our team develops and validates assays for toxicokinetic analysis, immunogenicity testing, and biomarker analysis. With these developments, KCAS Bio provides robust and reproducible data that can characterize drug exposure, evaluate immune responses, and identify early biomarkers for toxicity. Through precise, validated methods and a commitment to scientific integrity, KCAS Bio enables data-driven insights that inform risk assessment and regulatory decision-making in preclinical development.
Sharing Insight and Advancing Science
KCAS Bio’s attendance at the ACT Meeting aligns with our commitment to advancing non-clinical and regulatory toxicology through bioanalytical support. As a partner to sponsors navigating early-stage drug development studies, this event offers a valuable platform to engage with toxicologists, regulatory professionals, and industry leaders. By participating, we stay informed on evolving safety assessment strategies, connect with collaborators, and showcase our specialized capabilities.
Meet With Us
Connect with KCAS Bio during the ACT 46th Annual Meeting to explore shared interests in toxicology, molecular analysis, and drug safety. Our team will be on-site and exhibiting to highlight our scientific capabilities and discuss how our experience in bioanalysis and molecular services can support your ongoing or future studies.